{"id":71434,"date":"2026-09-04T17:08:13","date_gmt":"2026-09-04T21:08:13","guid":{"rendered":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/anthropic-eyes-2-trillion-ipo-astrazeneca-wins-fda-nod-for-breast-cancer-drug\/71434\/"},"modified":"2026-09-04T17:08:13","modified_gmt":"2026-09-04T21:08:13","slug":"anthropic-eyes-2-trillion-ipo-astrazeneca-wins-fda-nod-for-breast-cancer-drug","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/anthropic-eyes-2-trillion-ipo-astrazeneca-wins-fda-nod-for-breast-cancer-drug\/71434\/","title":{"rendered":"Anthropic Eyes $2 Trillion IPO; AstraZeneca Wins FDA Nod for Breast Cancer Drug"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_86 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/anthropic-eyes-2-trillion-ipo-astrazeneca-wins-fda-nod-for-breast-cancer-drug\/71434\/#Key_Takeaways\" >Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/anthropic-eyes-2-trillion-ipo-astrazeneca-wins-fda-nod-for-breast-cancer-drug\/71434\/#Anthropic_Targets_Record-Breaking_2_Trillion_Valuation\" >Anthropic Targets Record-Breaking $2 Trillion Valuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/anthropic-eyes-2-trillion-ipo-astrazeneca-wins-fda-nod-for-breast-cancer-drug\/71434\/#FDA_Approves_AstraZenecas_Etcamah_for_Advanced_Breast_Cancer\" >FDA Approves AstraZeneca\u2019s Etcamah for Advanced Breast Cancer<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/anthropic-eyes-2-trillion-ipo-astrazeneca-wins-fda-nod-for-breast-cancer-drug\/71434\/#Markets_Retreat_Following_Strong_Labor_Data\" >Markets Retreat Following Strong Labor Data<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/anthropic-eyes-2-trillion-ipo-astrazeneca-wins-fda-nod-for-breast-cancer-drug\/71434\/#DOJ_Denies_%22Pause%22_on_Canada_Antitrust_Cooperation\" >DOJ Denies &quot;Pause&quot; on Canada Antitrust Cooperation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/anthropic-eyes-2-trillion-ipo-astrazeneca-wins-fda-nod-for-breast-cancer-drug\/71434\/#Federal_Reserve_Releases_Weekly_H8_Banking_Data\" >Federal Reserve Releases Weekly H.8 Banking Data<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways\"><\/span>Key Takeaways<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Anthropic<\/strong> is reportedly finalizing deals with <strong>Morgan Stanley (<a href=\"\/stock\/MS\">MS<\/a>)<\/strong> and <strong>Goldman Sachs (<a href=\"\/stock\/GS\">GS<\/a>)<\/strong> for a blockbuster IPO that could value the AI startup at <strong>$2 trillion<\/strong>.<\/li>\n<li>The <strong>FDA<\/strong> granted accelerated approval to <strong>AstraZeneca\u2019s (<a href=\"\/stock\/AZN\">AZN<\/a>)<\/strong> Etcamah (camizestrant) for advanced breast cancer, marking a milestone in mutation-guided therapy.<\/li>\n<li>US markets closed lower on Friday, with the <strong><a href=\"https:\/\/stockmarketwatch.com\/indices\/dowjones\/today\" data-internallinksmanager029f6b8e52c=\"1\" title=\"Dow Jones Today\">Dow Jones<\/a><\/strong> falling <strong>287.77 points (0.54%)<\/strong> to <strong>53,398.34<\/strong> as investors weighed a strong jobs report against future interest rate paths.<\/li>\n<li>The <strong>US Justice Department<\/strong> officially refuted reports that it instructed its Antitrust Division to pause cooperation with the Canadian government, calling the claims &quot;false.&quot;<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Anthropic_Targets_Record-Breaking_2_Trillion_Valuation\"><\/span>Anthropic Targets Record-Breaking $2 Trillion Valuation<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>AI powerhouse <strong>Anthropic<\/strong> is nearing a deal to name <strong>Morgan Stanley (<a href=\"\/stock\/MS\">MS<\/a>)<\/strong> as the &quot;lead left&quot; underwriter and <strong>Goldman Sachs (<a href=\"\/stock\/GS\">GS<\/a>)<\/strong> as the stabilization agent for its upcoming initial public offering. According to the <em>Financial Times<\/em>, the company could publicly file its prospectus as early as next week, targeting a valuation of <strong>$2 trillion or more<\/strong>. This offering would rival the scale of recent major listings like SpaceX and represents a significant test of investor appetite for high-growth artificial intelligence ventures.<\/p>\n<p>The company is also reportedly securing a <strong>$15 billion revolving credit facility<\/strong> to bolster its balance sheet ahead of the debut. Other major financial institutions, including <strong>JPMorgan Chase (<a href=\"\/stock\/JPM\">JPM<\/a>)<\/strong>, <strong>Citigroup (<a href=\"\/stock\/C\">C<\/a>)<\/strong>, and <strong>Barclays (<a href=\"\/stock\/BCS\">BCS<\/a>)<\/strong>, are expected to take senior roles in the deal. <em>Market analysts suggest the IPO could take place as early as October 2026, potentially beating rival OpenAI to the public markets.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"FDA_Approves_AstraZenecas_Etcamah_for_Advanced_Breast_Cancer\"><\/span>FDA Approves AstraZeneca\u2019s Etcamah for Advanced Breast Cancer<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>US Food and Drug Administration (FDA)<\/strong> has granted accelerated approval to <strong>AstraZeneca\u2019s (<a href=\"\/stock\/AZN\">AZN<\/a>)<\/strong> Etcamah (camizestrant) in combination with CDK4\/6 inhibitors. The treatment is indicated for adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer who exhibit the <strong>ESR1 mutation<\/strong>. This mutation is a common form of acquired resistance, appearing in nearly <strong>40% of patients<\/strong> after initial endocrine therapy.<\/p>\n<p>Clinical data from the <strong>SERENA-6 trial<\/strong> supported the decision, showing that Etcamah improved median progression-free survival to <strong>16 months<\/strong>, compared to <strong>9.2 months<\/strong> for the standard of care. This approval is notable as the first for a cancer therapy guided by the detection of a resistance mutation in circulating tumor DNA (ctDNA) before traditional imaging shows disease progression. The FDA also authorized <strong>Guardant Health\u2019s (<a href=\"\/stock\/GH\">GH<\/a>)<\/strong> Guardant360 CDx as the companion diagnostic for patient selection.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Markets_Retreat_Following_Strong_Labor_Data\"><\/span>Markets Retreat Following Strong Labor Data<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Wall Street indices finished the session in the red on Friday as a robust August jobs report complicated the outlook for Federal Reserve policy. The <strong><a href=\"https:\/\/stockmarketwatch.com\/indices\/sp500\/today\" data-internallinksmanager029f6b8e52c=\"3\" title=\"snp500 today\">S&amp;P 500<\/a><\/strong> slipped <strong>32.62 points (0.42%)<\/strong> to close at <strong>7,715.09<\/strong>, while the tech-heavy <strong>Nasdaq<\/strong> fell <strong>72.13 points (0.27%)<\/strong> to <strong>26,511.93<\/strong>. Despite the daily dip, major indices remained up for the week, supported by earlier comments from Fed officials suggesting a potential pause in rate hikes if inflation remains stable.<\/p>\n<p>Individual stock performance was mixed, with <strong>Apple (<a href=\"\/stock\/AAPL\">AAPL<\/a>)<\/strong> weighing on the tech sector following reports of production volume issues for its upcoming foldable devices. Conversely, <strong><a href=\"https:\/\/stockmarketwatch.com\/stock\/MU\" data-internallinksmanager029f6b8e52c=\"20\" title=\"Stock: MU\">Micron<\/a> Technology (<a href=\"\/stock\/MU\">MU<\/a>)<\/strong> saw gains after announcing plans to double production of its AI-focused high-bandwidth memory. <em>Traders are now shifting focus to next week&#39;s consumer and producer price indices for further clues on the Fed&#39;s September 15-16 meeting.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"DOJ_Denies_%22Pause%22_on_Canada_Antitrust_Cooperation\"><\/span>DOJ Denies &quot;Pause&quot; on Canada Antitrust Cooperation<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>US Justice Department (DOJ)<\/strong> issued a firm denial on Friday regarding reports that it had ordered a halt to antitrust cooperation with the Canadian government. The department characterized the report as <strong>&quot;false,&quot;<\/strong> clarifying that while a specific meeting was delayed to allow for more preparation, no broad directive to stop work was ever issued.<\/p>\n<p>The initial report, which surfaced amid an escalating trade dispute between Washington and Ottawa, had suggested that internal emails directed officials to pause all engagement on policy issues. <em>The clarification comes as both nations continue to navigate complex trade tensions involving tariffs on billions of dollars worth of goods.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Federal_Reserve_Releases_Weekly_H8_Banking_Data\"><\/span>Federal Reserve Releases Weekly H.8 Banking Data<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Federal Reserve<\/strong> released its weekly <strong>H.8 report<\/strong>, providing the latest snapshot of assets and liabilities for commercial banks in the United States. The data, which tracks bank credit, loans, and leases, showed that total assets for all commercial banks stood at approximately <strong>$25.65 trillion<\/strong> as of late August. The H.8 release remains a critical tool for economists monitoring the health of the US banking system and the flow of credit to businesses and consumers.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Anthropic is reportedly finalizing deals with Morgan Stanley (MS) and Goldman Sachs (GS) for a blockbuster IPO that [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[4380,4537,5528,5833,5983,6593,7508,7765],"class_list":["post-71434","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-stock-market","tag-anthropic","tag-doj","tag-fda","tag-morgan-stanley-ms-stock-ms","tag-us-justice-department","tag-goldman-sachs-gs-stock-gs","tag-astrazeneca-azn-stock-azn"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/71434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=71434"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/71434\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=71434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=71434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=71434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}